Catheter Precision, Inc. announced on May 1, 2025, that new clinical data about its VIVO product is now available. This data was compiled and presented during three different abstract sessions at the 46th Annual Heart Rhythm Association Conference.
VIVO is a non-invasive mapping system designed to identify areas of ventricular arrhythmias pre-procedure. The presentation of this new data at a prominent conference highlights the ongoing clinical validation and utility of the system.
The dissemination of this clinical information to nearly 10,000 scientists and allied professionals at the conference is crucial for increasing awareness and understanding of VIVO's capabilities. This exposure can contribute to broader acceptance and adoption of the technology in the electrophysiology market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.